Antisense phosphorothioate oligonucleotides to NF-kappaB (RelA/NF-kappaB1) decrease interleukin-8 secretion from cultured normal human epidermal keratinocytes.

Mitsunori Ikeda; Yasuaki Hirose; Rie Hamada; Hideki Nakajima; Ken Miyoshi; Masaaki Matsumoto; Masahiro Seike; Hajime Kodama

doi:10.1016/j.jdermsci.2004.06.001

Home/Archive/PubMed

PubMed · 15381247

Antisense phosphorothioate oligonucleotides to NF-kappaB (RelA/NF-kappaB1) decrease interleukin-8 secretion from cultured normal human epidermal keratinocytes.

Mitsunori Ikeda·Yasuaki Hirose·Rie Hamada·Hideki Nakajima·Ken Miyoshi·Masaaki Matsumoto·Masahiro Seike·Hajime Kodama

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Cells, Cultured Epidermal Cells Humans Interleukin-8 Keratinocytes NF-kappa B Oligonucleotides, Antisense Transcription Factor RelA Letter

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Mitsunori Ikeda, Yasuaki Hirose, Rie Hamada, Hideki Nakajima, Ken Miyoshi, Masaaki Matsumoto, Masahiro Seike, Hajime Kodama. 2004. Antisense phosphorothioate oligonucleotides to NF-kappaB (RelA/NF-kappaB1) decrease interleukin-8 secretion from cultured normal human epidermal keratinocytes.. https://doi.org/10.1016/j.jdermsci.2004.06.001

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Activation of cell-survival transcription factor NFkappaB in L1Ig6-stimulated endothelial cells.

Ligation of the integrin alpha(v)beta(3) in endothelial cells has been shown to be important for their survival. Such ligation induces signalling events merging into the Raf-Ras-ERK cascade that eventually induces activation of nuclear factor kappa B (NFkappaB), leading to its phosphorylation and nuclear translocation and thus inhibiting apoptosis. Here, the recombinant sixth immunoglobulin-like domain of cell adhesion molecules L1 (L1Ig6), a ligand for integrin alpha(v)beta(3), was explored as a component of vascular implant surfaces to initiate the NFkappaB-cell survival pathway. This supposition was supported. Specifically, NFkappaB-p65 was expressed in human umbilical vein endothelial cells (HUVECs) and when stimulated on L1Ig6, the phosphorylated form was found in the nucleus in over 60% of the cells. NFkappaB was not translocated into the nucleus on a number of other extracellular matrix substrates examined or when fibroblasts were cultured on L1Ig6. NFkappaB phosphorylation and nuclear translocation could be inhibited by blocking ligation of alpha(v)beta(3) by L1Ig6 with an antibody recognizing alpha(v)beta(3), with a cyclic RGD peptide, and with soluble L1Ig6. Moreover, blocking of alpha(v)beta(3) interaction with L1Ig6 was correlated with induction of apoptosis. Thus, these experiments demonstrate that L1Ig6 may be useful as alpha(v)beta(3) ligand for the induction of endothelial survival pathways mediated by NFkappaB-p65.

Cells, Cultured↗

PubMed2006

Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.

The chemokine receptors CXCR4 and CCR5 are required for HIV-1 to enter cells, and the progression of HIV-1 infection to AIDS involves a switch in the co-receptor usage of the virus from CCR5 to CXCR4. These receptors therefore make attractive candidates for therapeutic intervention, and we have investigated the silencing of their genes by using ribozymes and single-stranded antisense RNAs. In the present study, we demonstrate using ribozymes that a depletion of CXCR4 and CCR5 mRNAs can be achieved simultaneously in human PBMCs (peripheral blood mononuclear cells), cells commonly used by the virus for infection and replication. Ribozyme activity leads to an inhibition of the cell-surface expression of both CCR5 and CXCR4, resulting in a significant inhibition of HIV-1 replication when PBMCs are challenged with the virus. In addition, we show that small single-stranded antisense RNAs can also be used to silence CCR5 and CXCR4 genes when delivered to PBMCs. This silencing is caused by selective degradation of receptor mRNAs.

Cells, Cultured↗

PubMed2006

Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol.

Prevention of cardiovascular disease through nutritional supplements is growing in popularity throughout the world. Multiple epidemiologic studies found that moderate consumption of alcohol, particularly red wine, lowers mortality rates from coronary heart diseases (CHD). Chronic inflammation and atherosclerosis associated with CHD culminate in aberrant intravascular expression of tissue factor (TF), which triggers blood coagulation leading to thrombosis, a major cause for heart attack. We showed earlier that two red wine phenolics, resveratrol and quercetin, suppressed TF induction in endothelial cells. In the present study, we investigated efficacy of seven resveratrol derivatives, which were shown to be effective in regulating cancer cell growth in vitro at much lower concentrations than the parent compound resveratrol, in inhibiting TF induction in peripheral blood mononuclear cells (PBMCs). We also tested possible synergistic effects of resveratrol and quercetin with the other major red wine phenolics in suppression of lipopolysaccharide-induced TF expression in human PBMCs. We found that several resveratrol derivatives were 2- to 10-fold more efficient than resveratrol in inhibiting TF induction. Our study found no evidence for synergism among red wine polyphenolics. These data suggest that structural alterations of resveratrol can be effective in producing potent antithrombotic agents that will have therapeutic potential in the improvement of cardiovascular health and prevention of CHD. Among major red wine phenolics, quercetin appears to be the predominant suppressor of TF induction.

Cells, Cultured↗